Company / Book Value per Share
Travere Therapeutics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.313
FY2025
5-year range
$0.686 / $4.234
FY2021-FY2025
Trend
+67.5%
vs FY2024
Sector context
#160 of 209
Health Care
What the data says
Travere Therapeutics, Inc.'s book value per share of $1.313 is lower than 77% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 10 years, ranging from -$1.022 in FY2016 to $7.913 in FY2017.
Based on SEC 10-K filings.
$1.313 in FY2025 with a 5-year CAGR of -29.2%.
Declined from $3.123 to $1.313 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +24.2%
- 5-Year CAGR
- -29.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 209This company $1.313 Sector average $189.406
▼
-99.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -29.2%, indicating a declining trend.
- In FY2025, book value per share increased 67.5% year-over-year.
- Ranks #160 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.313 | +67.5% |
| FY2024 | $0.784 | -74.9% |
| FY2023 | $3.123 | +355.5% |
| FY2022 | $0.686 | -83.8% |
| FY2021 | $4.234 | -42.7% |
| FY2020 | $7.386 | +4.3% |
| FY2019 | $7.082 | -9.4% |
| FY2018 | $7.817 | -1.2% |
| FY2017 | $7.913 | +874.7% |
| FY2016 | -$1.022 | -108.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026